GO:1903311 | regulation of mRNA metabolic process | 17.74% (11/62) | 4.08 | 0.0 | 0.0 |
GO:0061013 | regulation of mRNA catabolic process | 11.29% (7/62) | 4.24 | 0.0 | 4.3e-05 |
GO:0050684 | regulation of mRNA processing | 11.29% (7/62) | 4.24 | 0.0 | 4.3e-05 |
GO:0006396 | RNA processing | 22.58% (14/62) | 2.38 | 0.0 | 8.6e-05 |
GO:0003723 | RNA binding | 27.42% (17/62) | 2.08 | 0.0 | 9.5e-05 |
GO:0016070 | RNA metabolic process | 25.81% (16/62) | 2.11 | 0.0 | 0.000111 |
GO:0090304 | nucleic acid metabolic process | 29.03% (18/62) | 1.82 | 2e-06 | 0.000314 |
GO:0036002 | pre-mRNA binding | 6.45% (4/62) | 5.15 | 5e-06 | 0.000883 |
GO:0016604 | nuclear body | 12.9% (8/62) | 2.9 | 1.2e-05 | 0.001599 |
GO:0005681 | spliceosomal complex | 9.68% (6/62) | 3.6 | 1.1e-05 | 0.001615 |
GO:0000398 | mRNA splicing, via spliceosome | 8.06% (5/62) | 4.03 | 1.4e-05 | 0.00179 |
GO:0043488 | regulation of mRNA stability | 8.06% (5/62) | 3.95 | 1.9e-05 | 0.002142 |
GO:0006397 | mRNA processing | 11.29% (7/62) | 3.05 | 2.1e-05 | 0.00226 |
GO:0006139 | nucleobase-containing compound metabolic process | 29.03% (18/62) | 1.52 | 2.7e-05 | 0.002452 |
GO:0009894 | regulation of catabolic process | 14.52% (9/62) | 2.48 | 3.1e-05 | 0.002488 |
GO:0008380 | RNA splicing | 9.68% (6/62) | 3.37 | 2.6e-05 | 0.002544 |
GO:0003676 | nucleic acid binding | 35.48% (22/62) | 1.29 | 3.4e-05 | 0.00256 |
GO:0031329 | regulation of cellular catabolic process | 12.9% (8/62) | 2.67 | 3.6e-05 | 0.002619 |
GO:0043487 | regulation of RNA stability | 8.06% (5/62) | 3.8 | 3.1e-05 | 0.002623 |
GO:0043484 | regulation of RNA splicing | 8.06% (5/62) | 3.68 | 4.6e-05 | 0.002731 |
GO:0010608 | post-transcriptional regulation of gene expression | 12.9% (8/62) | 2.61 | 4.8e-05 | 0.002736 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 8.06% (5/62) | 3.72 | 4e-05 | 0.002738 |
GO:0003730 | mRNA 3'-UTR binding | 6.45% (4/62) | 4.36 | 4.5e-05 | 0.00282 |
GO:0031016 | pancreas development | 3.23% (2/62) | 7.49 | 5.2e-05 | 0.002838 |
GO:0000375 | RNA splicing, via transesterification reactions | 8.06% (5/62) | 3.69 | 4.5e-05 | 0.002934 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 29.03% (18/62) | 1.43 | 6.3e-05 | 0.003201 |
GO:0006376 | mRNA splice site selection | 4.84% (3/62) | 5.3 | 6.2e-05 | 0.003296 |
GO:0010628 | positive regulation of gene expression | 12.9% (8/62) | 2.45 | 0.0001 | 0.004921 |
GO:0005684 | U2-type spliceosomal complex | 6.45% (4/62) | 4.02 | 0.000111 | 0.005073 |
GO:0097550 | transcription preinitiation complex | 3.23% (2/62) | 6.98 | 0.00011 | 0.005227 |
GO:0016071 | mRNA metabolic process | 12.9% (8/62) | 2.37 | 0.000154 | 0.006807 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 6.45% (4/62) | 3.76 | 0.000223 | 0.00957 |
GO:2000628 | regulation of miRNA metabolic process | 3.23% (2/62) | 6.39 | 0.000256 | 0.010663 |
GO:0051252 | regulation of RNA metabolic process | 25.81% (16/62) | 1.38 | 0.000268 | 0.010814 |
GO:0000389 | mRNA 3'-splice site recognition | 3.23% (2/62) | 6.21 | 0.000332 | 0.012996 |
GO:0048513 | animal organ development | 12.9% (8/62) | 2.19 | 0.000352 | 0.013418 |
GO:0000243 | commitment complex | 3.23% (2/62) | 6.13 | 0.000373 | 0.013452 |
GO:1990904 | ribonucleoprotein complex | 12.9% (8/62) | 2.18 | 0.000372 | 0.013778 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 3.23% (2/62) | 5.98 | 0.000462 | 0.016244 |
GO:0010468 | regulation of gene expression | 29.03% (18/62) | 1.18 | 0.000563 | 0.018402 |
GO:0140513 | nuclear protein-containing complex | 14.52% (9/62) | 1.93 | 0.000537 | 0.018424 |
GO:0051123 | RNA polymerase II preinitiation complex assembly | 3.23% (2/62) | 5.84 | 0.00056 | 0.018748 |
GO:0003727 | single-stranded RNA binding | 6.45% (4/62) | 3.32 | 0.000712 | 0.022722 |
GO:0046483 | heterocycle metabolic process | 29.03% (18/62) | 1.14 | 0.000786 | 0.023976 |
GO:0070897 | transcription preinitiation complex assembly | 3.23% (2/62) | 5.6 | 0.000785 | 0.024478 |
GO:0140098 | catalytic activity, acting on RNA | 9.68% (6/62) | 2.43 | 0.000847 | 0.025276 |
GO:0051171 | regulation of nitrogen compound metabolic process | 30.65% (19/62) | 1.07 | 0.000947 | 0.027641 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 11.29% (7/62) | 2.12 | 0.001101 | 0.03147 |
GO:0034641 | cellular nitrogen compound metabolic process | 29.03% (18/62) | 1.09 | 0.001188 | 0.033251 |
GO:0030626 | U12 snRNA binding | 1.61% (1/62) | 9.3 | 0.001586 | 0.03627 |
GO:0002144 | cytosolic tRNA wobble base thiouridylase complex | 1.61% (1/62) | 9.3 | 0.001586 | 0.03627 |
GO:0106054 | tRNA U34 sulfurtransferase activity | 1.61% (1/62) | 9.3 | 0.001586 | 0.03627 |
GO:0039595 | induction by virus of catabolism of host mRNA | 1.61% (1/62) | 9.3 | 0.001586 | 0.03627 |
GO:0039644 | suppression by virus of host NF-kappaB cascade | 1.61% (1/62) | 9.3 | 0.001586 | 0.03627 |
GO:0002063 | chondrocyte development | 1.61% (1/62) | 9.3 | 0.001586 | 0.03627 |
GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation | 1.61% (1/62) | 9.3 | 0.001586 | 0.03627 |
GO:1902010 | negative regulation of translation in response to endoplasmic reticulum stress | 1.61% (1/62) | 9.3 | 0.001586 | 0.03627 |
GO:1903786 | regulation of glutathione biosynthetic process | 1.61% (1/62) | 9.3 | 0.001586 | 0.03627 |
GO:1903788 | positive regulation of glutathione biosynthetic process | 1.61% (1/62) | 9.3 | 0.001586 | 0.03627 |
GO:0061014 | positive regulation of mRNA catabolic process | 4.84% (3/62) | 3.8 | 0.001341 | 0.036796 |
GO:0005689 | U12-type spliceosomal complex | 3.23% (2/62) | 5.05 | 0.001677 | 0.037727 |
GO:0005669 | transcription factor TFIID complex | 3.23% (2/62) | 5.01 | 0.001766 | 0.037863 |
GO:0016251 | RNA polymerase II general transcription initiation factor activity | 3.23% (2/62) | 5.01 | 0.001766 | 0.037863 |
GO:0003677 | DNA binding | 20.97% (13/62) | 1.31 | 0.001761 | 0.038969 |
GO:0007417 | central nervous system development | 3.23% (2/62) | 4.98 | 0.001857 | 0.039203 |
GO:0022618 | ribonucleoprotein complex assembly | 6.45% (4/62) | 2.91 | 0.001999 | 0.04156 |
GO:0080090 | regulation of primary metabolic process | 30.65% (19/62) | 0.98 | 0.002069 | 0.042374 |
GO:0005686 | U2 snRNP | 3.23% (2/62) | 4.87 | 0.002144 | 0.042623 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 9.68% (6/62) | 2.17 | 0.002115 | 0.042667 |
GO:0000245 | spliceosomal complex assembly | 3.23% (2/62) | 4.81 | 0.002345 | 0.044692 |
GO:0004540 | ribonuclease activity | 4.84% (3/62) | 3.52 | 0.002327 | 0.044968 |
GO:0016607 | nuclear speck | 6.45% (4/62) | 2.86 | 0.002294 | 0.04497 |
GO:0071826 | ribonucleoprotein complex subunit organization | 6.45% (4/62) | 2.83 | 0.002465 | 0.04633 |
GO:0004532 | exoribonuclease activity | 3.23% (2/62) | 4.75 | 0.002556 | 0.046752 |
GO:0060255 | regulation of macromolecule metabolic process | 30.65% (19/62) | 0.96 | 0.002545 | 0.047184 |
GO:0043170 | macromolecule metabolic process | 38.71% (24/62) | 0.79 | 0.002702 | 0.04877 |